PBRM1 and nonpapillary renal cell carcinoma: Interestingly, higher proportion of mutation for both TP53 and BAP1 was observed in T-eff group compared to Angio group, and PBRM1 mutation with Angio compared to T-eff group of ccRCC patients (Supplementary Table ST3).